Company Filing History:
Years Active: 2017
Title: Douglas Cruise: Innovator in Pharmaceutical Chemistry
Introduction
Douglas Cruise is a notable inventor based in San Diego, CA (US). He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of innovative drug compounds. With a total of 3 patents, his work has had a meaningful impact on the industry.
Latest Patents
One of his latest patents is the synthesis of the PARP inhibitor talazoparib. This patent provides a new method for preparing this important compound, which is crucial in cancer treatment. Another significant patent involves the process of preparing (E)-3-(4-methoxyphenyl)-N-methyl-N-((6,7,8,9-tetrahydro-5H-benzo-[7]annulen-2-yl)methyl)prop-2-en-1-amine. This patent outlines a new method for preparing this compound as a drug intermediate, showcasing his innovative approach to pharmaceutical development.
Career Highlights
Throughout his career, Douglas has focused on creating effective solutions in drug synthesis. His expertise in this area has led to the successful development of multiple patents that contribute to advancements in medicine. His work is characterized by a commitment to improving therapeutic options for patients.
Collaborations
Douglas has collaborated with talented individuals in his field, including Yong Xu and Peter W Yohi. These partnerships have fostered a collaborative environment that enhances the innovation process and leads to groundbreaking discoveries.
Conclusion
In summary, Douglas Cruise is a distinguished inventor whose work in pharmaceutical chemistry has resulted in valuable patents and innovative drug synthesis methods. His contributions continue to influence the field and improve patient care.